Report Thumbnail
Product Code LP09155134866M8
Published Date 2024/5/30
English101 PagesGlobal

Global Bordetella Pertussis ELISA Kits Market Growth 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP09155134866M8◆The May 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/5/30
English 101 PagesGlobal

Global Bordetella Pertussis ELISA Kits Market Growth 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

Bordetella pertussis ELISA Kits are diagnostic kits used to detect Bordetella pertussis, the causative agent of whooping cough. These kits employ the Enzyme-Linked Immunosorbent Assay (ELISA) method to identify specific antigens present in patient samples, providing a reliable and sensitive tool for healthcare professionals to diagnose and monitor the disease. Bordetella pertussis ELISA Kits are essential for effective disease control and prevention programs.
The global Bordetella Pertussis ELISA Kits market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Bordetella Pertussis ELISA Kits Industry Forecast” looks at past sales and reviews total world Bordetella Pertussis ELISA Kits sales in 2023, providing a comprehensive analysis by region and market sector of projected Bordetella Pertussis ELISA Kits sales for 2024 through 2030. With Bordetella Pertussis ELISA Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bordetella Pertussis ELISA Kits industry.
This Insight Report provides a comprehensive analysis of the global Bordetella Pertussis ELISA Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bordetella Pertussis ELISA Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bordetella Pertussis ELISA Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bordetella Pertussis ELISA Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bordetella Pertussis ELISA Kits.
The industry trend for Bordetella pertussis ELISA Kits is focused on developing more specific and sensitive detection methods to improve accuracy and reduce false-positive results. Manufacturers are exploring new technologies and methodologies to enhance the sensitivity and specificity of Bordetella pertussis ELISA Kits, while also ensuring ease of use and cost-effectiveness. Additionally, there is a growing emphasis on integrated testing solutions that combine various diagnostic tools to provide comprehensive and accurate diagnosis of whooping cough. As awareness of whooping cough increases, the industry is evolving to meet the demand for accurate and timely diagnostic solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Bordetella Pertussis ELISA Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
IgG
IgM
Segmentation by Application:
Laboratory
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MyBioSource
XpressBio
Abbexa
IBL
Biorbyt
DEMEDITEC Diagnostics
Abnova
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bordetella Pertussis ELISA Kits market?
What factors are driving Bordetella Pertussis ELISA Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bordetella Pertussis ELISA Kits market opportunities vary by end market size?
How does Bordetella Pertussis ELISA Kits break out by Type, by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Bordetella Pertussis ELISA Kits Annual Sales 2019-2030
      • 2.1.2 World Current & Future Analysis for Bordetella Pertussis ELISA Kits by Geographic Region, 2019, 2023 & 2030
      • 2.1.3 World Current & Future Analysis for Bordetella Pertussis ELISA Kits by Country/Region, 2019, 2023 & 2030
    • 2.2 Bordetella Pertussis ELISA Kits Segment by Type
      • 2.2.1 IgG
      • 2.2.2 IgM
    • 2.3 Bordetella Pertussis ELISA Kits Sales by Type
      • 2.3.1 Global Bordetella Pertussis ELISA Kits Sales Market Share by Type (2019-2024)
      • 2.3.2 Global Bordetella Pertussis ELISA Kits Revenue and Market Share by Type (2019-2024)
      • 2.3.3 Global Bordetella Pertussis ELISA Kits Sale Price by Type (2019-2024)
    • 2.4 Bordetella Pertussis ELISA Kits Segment by Application
      • 2.4.1 Laboratory
      • 2.4.2 Hospital
      • 2.4.3 Others
    • 2.5 Bordetella Pertussis ELISA Kits Sales by Application
      • 2.5.1 Global Bordetella Pertussis ELISA Kits Sale Market Share by Application (2019-2024)
      • 2.5.2 Global Bordetella Pertussis ELISA Kits Revenue and Market Share by Application (2019-2024)
      • 2.5.3 Global Bordetella Pertussis ELISA Kits Sale Price by Application (2019-2024)
  • 3 Global by Company

    • 3.1 Global Bordetella Pertussis ELISA Kits Breakdown Data by Company
      • 3.1.1 Global Bordetella Pertussis ELISA Kits Annual Sales by Company (2019-2024)
      • 3.1.2 Global Bordetella Pertussis ELISA Kits Sales Market Share by Company (2019-2024)
    • 3.2 Global Bordetella Pertussis ELISA Kits Annual Revenue by Company (2019-2024)
      • 3.2.1 Global Bordetella Pertussis ELISA Kits Revenue by Company (2019-2024)
      • 3.2.2 Global Bordetella Pertussis ELISA Kits Revenue Market Share by Company (2019-2024)
    • 3.3 Global Bordetella Pertussis ELISA Kits Sale Price by Company
    • 3.4 Key Manufacturers Bordetella Pertussis ELISA Kits Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Bordetella Pertussis ELISA Kits Product Location Distribution
      • 3.4.2 Players Bordetella Pertussis ELISA Kits Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Bordetella Pertussis ELISA Kits by Geographic Region

    • 4.1 World Historic Bordetella Pertussis ELISA Kits Market Size by Geographic Region (2019-2024)
      • 4.1.1 Global Bordetella Pertussis ELISA Kits Annual Sales by Geographic Region (2019-2024)
      • 4.1.2 Global Bordetella Pertussis ELISA Kits Annual Revenue by Geographic Region (2019-2024)
    • 4.2 World Historic Bordetella Pertussis ELISA Kits Market Size by Country/Region (2019-2024)
      • 4.2.1 Global Bordetella Pertussis ELISA Kits Annual Sales by Country/Region (2019-2024)
      • 4.2.2 Global Bordetella Pertussis ELISA Kits Annual Revenue by Country/Region (2019-2024)
    • 4.3 Americas Bordetella Pertussis ELISA Kits Sales Growth
    • 4.4 APAC Bordetella Pertussis ELISA Kits Sales Growth
    • 4.5 Europe Bordetella Pertussis ELISA Kits Sales Growth
    • 4.6 Middle East & Africa Bordetella Pertussis ELISA Kits Sales Growth
  • 5 Americas

    • 5.1 Americas Bordetella Pertussis ELISA Kits Sales by Country
      • 5.1.1 Americas Bordetella Pertussis ELISA Kits Sales by Country (2019-2024)
      • 5.1.2 Americas Bordetella Pertussis ELISA Kits Revenue by Country (2019-2024)
    • 5.2 Americas Bordetella Pertussis ELISA Kits Sales by Type (2019-2024)
    • 5.3 Americas Bordetella Pertussis ELISA Kits Sales by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Bordetella Pertussis ELISA Kits Sales by Region
      • 6.1.1 APAC Bordetella Pertussis ELISA Kits Sales by Region (2019-2024)
      • 6.1.2 APAC Bordetella Pertussis ELISA Kits Revenue by Region (2019-2024)
    • 6.2 APAC Bordetella Pertussis ELISA Kits Sales by Type (2019-2024)
    • 6.3 APAC Bordetella Pertussis ELISA Kits Sales by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Bordetella Pertussis ELISA Kits by Country
      • 7.1.1 Europe Bordetella Pertussis ELISA Kits Sales by Country (2019-2024)
      • 7.1.2 Europe Bordetella Pertussis ELISA Kits Revenue by Country (2019-2024)
    • 7.2 Europe Bordetella Pertussis ELISA Kits Sales by Type (2019-2024)
    • 7.3 Europe Bordetella Pertussis ELISA Kits Sales by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Bordetella Pertussis ELISA Kits by Country
      • 8.1.1 Middle East & Africa Bordetella Pertussis ELISA Kits Sales by Country (2019-2024)
      • 8.1.2 Middle East & Africa Bordetella Pertussis ELISA Kits Revenue by Country (2019-2024)
    • 8.2 Middle East & Africa Bordetella Pertussis ELISA Kits Sales by Type (2019-2024)
    • 8.3 Middle East & Africa Bordetella Pertussis ELISA Kits Sales by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Bordetella Pertussis ELISA Kits
    • 10.3 Manufacturing Process Analysis of Bordetella Pertussis ELISA Kits
    • 10.4 Industry Chain Structure of Bordetella Pertussis ELISA Kits
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Bordetella Pertussis ELISA Kits Distributors
    • 11.3 Bordetella Pertussis ELISA Kits Customer
  • 12 World Forecast Review for Bordetella Pertussis ELISA Kits by Geographic Region

    • 12.1 Global Bordetella Pertussis ELISA Kits Market Size Forecast by Region
      • 12.1.1 Global Bordetella Pertussis ELISA Kits Forecast by Region (2025-2030)
      • 12.1.2 Global Bordetella Pertussis ELISA Kits Annual Revenue Forecast by Region (2025-2030)
    • 12.2 Americas Forecast by Country (2025-2030)
    • 12.3 APAC Forecast by Region (2025-2030)
    • 12.4 Europe Forecast by Country (2025-2030)
    • 12.5 Middle East & Africa Forecast by Country (2025-2030)
    • 12.6 Global Bordetella Pertussis ELISA Kits Forecast by Type (2025-2030)
    • 12.7 Global Bordetella Pertussis ELISA Kits Forecast by Application (2025-2030)
  • 13 Key Players Analysis

    • 13.1 MyBioSource
      • 13.1.1 MyBioSource Company Information
      • 13.1.2 MyBioSource Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.1.3 MyBioSource Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.1.4 MyBioSource Main Business Overview
      • 13.1.5 MyBioSource Latest Developments
    • 13.2 XpressBio
      • 13.2.1 XpressBio Company Information
      • 13.2.2 XpressBio Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.2.3 XpressBio Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.2.4 XpressBio Main Business Overview
      • 13.2.5 XpressBio Latest Developments
    • 13.3 Abbexa
      • 13.3.1 Abbexa Company Information
      • 13.3.2 Abbexa Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.3.3 Abbexa Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.3.4 Abbexa Main Business Overview
      • 13.3.5 Abbexa Latest Developments
    • 13.4 IBL
      • 13.4.1 IBL Company Information
      • 13.4.2 IBL Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.4.3 IBL Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.4.4 IBL Main Business Overview
      • 13.4.5 IBL Latest Developments
    • 13.5 Biorbyt
      • 13.5.1 Biorbyt Company Information
      • 13.5.2 Biorbyt Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.5.3 Biorbyt Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.5.4 Biorbyt Main Business Overview
      • 13.5.5 Biorbyt Latest Developments
    • 13.6 DEMEDITEC Diagnostics
      • 13.6.1 DEMEDITEC Diagnostics Company Information
      • 13.6.2 DEMEDITEC Diagnostics Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.6.3 DEMEDITEC Diagnostics Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.6.4 DEMEDITEC Diagnostics Main Business Overview
      • 13.6.5 DEMEDITEC Diagnostics Latest Developments
    • 13.7 Abnova
      • 13.7.1 Abnova Company Information
      • 13.7.2 Abnova Bordetella Pertussis ELISA Kits Product Portfolios and Specifications
      • 13.7.3 Abnova Bordetella Pertussis ELISA Kits Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.7.4 Abnova Main Business Overview
      • 13.7.5 Abnova Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.